Skip to main content
Top
Gepubliceerd in: Huisarts en wetenschap 7/2010

01-07-2010 | Onderzoek

CVRM door een praktijkverpleegkundige is effectief

Auteurs: ir. H. R. Voogdt-Pruis, dr. G. H. M. I. Beusmans, prof. dr. A. P. M. Gorgels, dr. A. D. M. Kester, prof.dr. J. W. van Ree

Gepubliceerd in: Huisarts en wetenschap | Uitgave 7/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

 

Voogdt-Pruis HR, Beusmans GHM, Gorgels APM, Kester ADM, Van Ree JW. CVRM door een praktijkverpleegkundige is effectief. Huisarts Wet 2010;7:362-7.

Inleiding

Preventie van hart- en vaatziekten vindt voor een substantieel deel in de eerste lijn plaats. Volgens de NHG/CBOrichtlijn Cardiovasculair risicomanagement (CVRM) uit 2006 kunnen praktijkondersteuners huisartsen bijstaan bij de preventie van HVZ. Wij onderzochten de klinische effectiviteit van CVRM door praktijkverpleegkundigen bij hoogrisicopatiënten na één jaar follow-up en vergeleken deze met CVRM door huisartsen.

Methode

Het betrof een prospectief, pragmatisch en gerandomiseerd onderzoek met Zelen-onderzoeksopzet in zes gezondheidscentra in Limburg (25 huisartsen, 6 praktijkondersteuners). In maart 2006 wezen we 1626 patiënten met een potentieel hoog risico op hart- en vaatziekten toe aan de praktijkverpleegkundigengroep (n = 808) of de huisartsengroep (n = 818). In totaal voldeden 701 patiënten aan de onderzoekscriteria. Als protocol gebruikten we de Praktijkwijzer die bij de CVRM-richtlijn behoort. We maten de veranderingen na één jaar follow-up voor de volgende risicofactoren: lipiden, systolische bloeddruk, BMI en rookgedrag.

Resultaten

Na één jaar follow-up daalden de risicofactoren in de praktijkverpleegkundigengroep sterker dan in de huisartsengroep. In het analysemodel, waarin andere beïnvloedende factoren constant gehouden waren, vonden we alleen een significant verschil tussen de twee groepen voor totaal cholesterol (p = 0,01, tweezijdige toetsing).

Conclusie

Praktijkverpleegkundigen bereiken gelijke of betere resultaten dan huisartsen bij het uitvoeren van CVRM. Daarom is het zinvol om praktijkverpleegkundigen bij CVRM te betrekken.
Literatuur
2.
go back to reference Vaartjes I, Peters RJG, Van Dis SJ, Bots M. Hart- en vaatziekten in Nederland 2008. Den Haag: De Nederlandse Hartstichting, 2008. Vaartjes I, Peters RJG, Van Dis SJ, Bots M. Hart- en vaatziekten in Nederland 2008. Den Haag: De Nederlandse Hartstichting, 2008.
4.
go back to reference De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2003;10:S1–S10.PubMedCrossRef De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2003;10:S1–S10.PubMedCrossRef
5.
go back to reference CBO, NHG. Richtlijn Cardiovasculair Risico Management 2006. Utrecht: CBO/NHG, 2006. CBO, NHG. Richtlijn Cardiovasculair Risico Management 2006. Utrecht: CBO/NHG, 2006.
6.
go back to reference Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356–62.PubMedCrossRef Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356–62.PubMedCrossRef
7.
go back to reference Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.PubMedCrossRef Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.PubMedCrossRef
8.
go back to reference Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002;105:310–5.PubMedCrossRef Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002;105:310–5.PubMedCrossRef
9.
go back to reference Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J hypertens 1998;16:1407–14.PubMedCrossRef Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J hypertens 1998;16:1407–14.PubMedCrossRef
10.
go back to reference Van den Berg M, de Bakker D. Introductie praktijkondersteuning op HBO-niveau in de huisartsenpraktijk in Nederland. Utrecht: NIVEL, 2003. Van den Berg M, de Bakker D. Introductie praktijkondersteuning op HBO-niveau in de huisartsenpraktijk in Nederland. Utrecht: NIVEL, 2003.
11.
go back to reference Meulepas MA, Jacobs JE, Lucas AE, Smeenk FW, Smeele I, Bottema BJ, et al. The feasibility of a primary care model for the management of COPD. Prim Care Respir J 2006;15:337–41.PubMedCrossRef Meulepas MA, Jacobs JE, Lucas AE, Smeenk FW, Smeele I, Bottema BJ, et al. The feasibility of a primary care model for the management of COPD. Prim Care Respir J 2006;15:337–41.PubMedCrossRef
12.
go back to reference Van Son L, Crebolder H, Van Hoef L, Beusmans G. De huisarts ondersteund. Huisarts Wet 2004;47:15–21.CrossRef Van Son L, Crebolder H, Van Hoef L, Beusmans G. De huisarts ondersteund. Huisarts Wet 2004;47:15–21.CrossRef
13.
go back to reference Aubert RE, Herman WH, Waters J, Moore W, Sutton D, Peterson BL, et al. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med 1998;129:605–12.PubMed Aubert RE, Herman WH, Waters J, Moore W, Sutton D, Peterson BL, et al. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med 1998;129:605–12.PubMed
14.
go back to reference Horrocks S, Anderson E, Salisbury C. Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors. BMJ 2002;324:819–23.PubMedCrossRef Horrocks S, Anderson E, Salisbury C. Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors. BMJ 2002;324:819–23.PubMedCrossRef
15.
go back to reference Laurant M, Reeves D, Hermens R, Braspenning J, Grol R, Sibbald B. Substitution of doctors by nurses in primary care. Cochrane Database Syst Rev 2005;2:CD001271. Laurant M, Reeves D, Hermens R, Braspenning J, Grol R, Sibbald B. Substitution of doctors by nurses in primary care. Cochrane Database Syst Rev 2005;2:CD001271.
16.
go back to reference Leenders F, Beusmans G, Swerts H, Gorgels T, Van Ree J. Een praktijkverpleegkundige hart- en vaatziekten op proef. Tijdschr Praktijkonderst 2006;1:45–50.CrossRef Leenders F, Beusmans G, Swerts H, Gorgels T, Van Ree J. Een praktijkverpleegkundige hart- en vaatziekten op proef. Tijdschr Praktijkonderst 2006;1:45–50.CrossRef
18.
go back to reference Schellings R, Kessels AG, Ter Riet G, Sturmans F, Widdershoven GA, Knottnerus JA. Indications and requirements for the use of prerandomization. J Clin Epidemiol 2009;62:393–9.PubMedCrossRef Schellings R, Kessels AG, Ter Riet G, Sturmans F, Widdershoven GA, Knottnerus JA. Indications and requirements for the use of prerandomization. J Clin Epidemiol 2009;62:393–9.PubMedCrossRef
20.
go back to reference Ebrahim S, Smith GD. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ 1997;314:1666–74.PubMedCrossRef Ebrahim S, Smith GD. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ 1997;314:1666–74.PubMedCrossRef
21.
go back to reference Martin TN, Irving RJ, Sutherland M, Sutherland K, Bloomfield P. Improving secondary prevention in coronary bypass patients: closing the audit loop. Heart 2005;91:456–9.PubMedCrossRef Martin TN, Irving RJ, Sutherland M, Sutherland K, Bloomfield P. Improving secondary prevention in coronary bypass patients: closing the audit loop. Heart 2005;91:456–9.PubMedCrossRef
22.
go back to reference EUROASPIRE. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554–72. EUROASPIRE. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554–72.
23.
go back to reference Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens 1998;16:1407–14.PubMedCrossRef Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens 1998;16:1407–14.PubMedCrossRef
24.
go back to reference Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325:652–54.PubMedCrossRef Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325:652–54.PubMedCrossRef
25.
go back to reference Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994;84:1086–93.PubMedCrossRef Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994;84:1086–93.PubMedCrossRef
26.
go back to reference McAdams MA, Van Dam RM, Hu FB. Comparison of self-reported and measured BMI as correlates of disease markers in US adults. Obesity (Silver Spring) 2007;15:188–96.CrossRef McAdams MA, Van Dam RM, Hu FB. Comparison of self-reported and measured BMI as correlates of disease markers in US adults. Obesity (Silver Spring) 2007;15:188–96.CrossRef
27.
go back to reference Nielen MMJ, Schellevis FG. Preventie in de huisartsenpraktijk anno 2008. Utrecht: NIVEL, 2008. Nielen MMJ, Schellevis FG. Preventie in de huisartsenpraktijk anno 2008. Utrecht: NIVEL, 2008.
28.
go back to reference Caruana E. Effectiveness of general practice nurse interventions in cardiac risk factor reduction among adults. J Adv Nurs 2008;62:530–1.PubMedCrossRef Caruana E. Effectiveness of general practice nurse interventions in cardiac risk factor reduction among adults. J Adv Nurs 2008;62:530–1.PubMedCrossRef
29.
go back to reference Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.PubMedCrossRef Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.PubMedCrossRef
30.
go back to reference Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008;371:1999–2012.PubMedCrossRef Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008;371:1999–2012.PubMedCrossRef
31.
go back to reference Khunti K, Stone M, Paul S, Baines J, Gisborne L, Farooqi A, et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart 2007;93:1398–405.PubMedCrossRef Khunti K, Stone M, Paul S, Baines J, Gisborne L, Farooqi A, et al. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart 2007;93:1398–405.PubMedCrossRef
32.
go back to reference McDonnell A, Crookes P, Davies S, Shewan J. Practice nurses and the prevention of cardiovascular disease and stroke: a literature review to promote evidence-based practice. Part I: rationale review methods, effectiveness of practice nurses and smoking cessation. Clin Eff Nurs 1997;I:189–97.CrossRef McDonnell A, Crookes P, Davies S, Shewan J. Practice nurses and the prevention of cardiovascular disease and stroke: a literature review to promote evidence-based practice. Part I: rationale review methods, effectiveness of practice nurses and smoking cessation. Clin Eff Nurs 1997;I:189–97.CrossRef
33.
go back to reference Danon-Hersch N, Marques-Vidal P, Bovet P, Chiolero A, Paccaud F, Pecoud A, et al. Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil 2009;16:66–72.PubMedCrossRef Danon-Hersch N, Marques-Vidal P, Bovet P, Chiolero A, Paccaud F, Pecoud A, et al. Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil 2009;16:66–72.PubMedCrossRef
34.
go back to reference Steinhagen-Thiessen E, Bramlage P, Losch C, Hauner H, Schunkert H, Vogt A, et al. Dyslipidemia in primary care –prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 2008;7:31.PubMedCrossRef Steinhagen-Thiessen E, Bramlage P, Losch C, Hauner H, Schunkert H, Vogt A, et al. Dyslipidemia in primary care –prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 2008;7:31.PubMedCrossRef
35.
go back to reference Kaasjager HAH, Van Dis SJ. Cardiovasculaire risicofactoren bij patiënten met hart- en vaatziekten. Den Haag: De Nederlandse Hartstichting, 2008. Kaasjager HAH, Van Dis SJ. Cardiovasculaire risicofactoren bij patiënten met hart- en vaatziekten. Den Haag: De Nederlandse Hartstichting, 2008.
36.
go back to reference Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009;373:929–40.PubMedCrossRef Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009;373:929–40.PubMedCrossRef
37.
go back to reference Metsemakers JF, Knottnerus JA, Van Schendel GJ, Kocken RJ, Limonard CB. Unlocking patients’ records in general practice for research, medical education and quality assurance: the Registration Network Family Practices. Int J Biomed Comput 1996;42:43–50.PubMedCrossRef Metsemakers JF, Knottnerus JA, Van Schendel GJ, Kocken RJ, Limonard CB. Unlocking patients’ records in general practice for research, medical education and quality assurance: the Registration Network Family Practices. Int J Biomed Comput 1996;42:43–50.PubMedCrossRef
38.
go back to reference Busch MCM. Preventie in de eerste lijn. Volksgezondheid Toekomst Verkenning: Nationaal Kompas Volksgezondheid. Utrecht: Rijksinstituut voor Volksgezondheid en Milieu (RIVM), 2005. Busch MCM. Preventie in de eerste lijn. Volksgezondheid Toekomst Verkenning: Nationaal Kompas Volksgezondheid. Utrecht: Rijksinstituut voor Volksgezondheid en Milieu (RIVM), 2005.
Metagegevens
Titel
CVRM door een praktijkverpleegkundige is effectief
Auteurs
ir. H. R. Voogdt-Pruis
dr. G. H. M. I. Beusmans
prof. dr. A. P. M. Gorgels
dr. A. D. M. Kester
prof.dr. J. W. van Ree
Publicatiedatum
01-07-2010
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Huisarts en wetenschap / Uitgave 7/2010
Print ISSN: 0018-7070
Elektronisch ISSN: 1876-5912
DOI
https://doi.org/10.1007/s12445-010-0166-5

Andere artikelen Uitgave 7/2010

Huisarts en wetenschap 7/2010 Naar de uitgave